Wuhan Jiulong Pharmaceutical

Wuhan Jiulong Pharmaceutical is a comprehensive pharmaceutical enterprise based in Wuhan, China, dedicated to the R&D, production, and sale of chemical APIs and finished drug products. The company maintains multiple GMP-certified production lines and specializes in treatments for chronic conditions such as diabetes and hypertension, as well as anti-infective therapies. Jiulong Pharmaceutical is recognized as a high-tech enterprise in Hubei Province and serves as a significant supplier of active ingredients for the global pharmaceutical supply chain. Their business model encompasses both independent product commercialization and contract development and manufacturing services. Key products in their portfolio include metformin, gliclazide, and various cardiovascular medications. The company focuses on high-quality chemical synthesis and large-scale manufacturing to meet international standards.